David Amsellem
Stock Analyst at Piper Sandler
(4.85)
# 389
Out of 4,969 analysts
934
Total ratings
60.1%
Success rate
15.1%
Average return
Main Sectors:
Stocks Rated by David Amsellem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings | Reiterated: Hold | $8 | $7.57 | +5.68% | 15 | Sep 10, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $310 | $245.87 | +26.08% | 70 | Sep 9, 2026 | |
| AMGN Amgen | Reiterated: Buy | $457 | $381.50 | +19.79% | 52 | Sep 8, 2026 | |
| BIIB Biogen | Reiterated: Buy | $225 → $245 | $217.36 | +12.72% | 32 | Sep 3, 2026 | |
| TEVA Teva Pharmaceutical Industries | Reiterated: Buy | $44 | $38.72 | +13.64% | 72 | Aug 27, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Buy | $165 | $111.80 | +47.58% | 34 | Aug 21, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $298 → $303 | $261.77 | +15.75% | 26 | Aug 20, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $258 | $216.58 | +19.12% | 27 | Aug 18, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $75 | $40.25 | +86.34% | 7 | Aug 17, 2026 | |
| PTHS Pelthos Therapeutics | Reiterated: Buy | $48 | $21.94 | +118.78% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $20 | $23.91 | -16.35% | 41 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $44 → $43 | $22.81 | +88.51% | 46 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $45.83 | +41.83% | 42 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $207 → $210 | $157.22 | +33.57% | 43 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $64.10 | +17.00% | 18 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 | $41.49 | +59.07% | 70 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $17.22 | -1.28% | 42 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $16.66 | -27.97% | 24 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $59 | $34.47 | +71.16% | 14 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.88 | +63.93% | 7 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $10.72 | +67.91% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $5 → $14 | $13.65 | +2.56% | 18 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 → $111 | $70.40 | +57.67% | 4 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $46 | $41.54 | +10.74% | 17 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $9 | $9.60 | n/a | 19 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $12 | $24.68 | n/a | 39 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4.16 | $8.25 | n/a | 64 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $18 | $4.17 | n/a | 9 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $12 | $1.83 | n/a | 12 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $17 | $0.18 | n/a | 29 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.0077 | n/a | 7 | May 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $3 | $26.26 | n/a | 5 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $175 | $0.0001 | n/a | 7 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $27.72 | n/a | 1 | Jan 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $1.24 | n/a | 10 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.0003 | n/a | 1 | Nov 11, 2013 |
Xeris Biopharma Holdings
Sep 10, 2026
Reiterated: Hold
Price Target: $8
Current: $7.57
Upside: +5.68%
Jazz Pharmaceuticals
Sep 9, 2026
Reiterated: Buy
Price Target: $310
Current: $245.87
Upside: +26.08%
Amgen
Sep 8, 2026
Reiterated: Buy
Price Target: $457
Current: $381.50
Upside: +19.79%
Biogen
Sep 3, 2026
Reiterated: Buy
Price Target: $225 → $245
Current: $217.36
Upside: +12.72%
Teva Pharmaceutical Industries
Aug 27, 2026
Reiterated: Buy
Price Target: $44
Current: $38.72
Upside: +13.64%
Corcept Therapeutics
Aug 21, 2026
Reiterated: Buy
Price Target: $165
Current: $111.80
Upside: +47.58%
AbbVie
Aug 20, 2026
Reiterated: Buy
Price Target: $298 → $303
Current: $261.77
Upside: +15.75%
Axsome Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $258
Current: $216.58
Upside: +19.12%
Definium Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $75
Current: $40.25
Upside: +86.34%
Pelthos Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $48
Current: $21.94
Upside: +118.78%
Aug 7, 2026
Reiterated: Hold
Price Target: $21 → $20
Current: $23.91
Upside: -16.35%
Aug 7, 2026
Reiterated: Hold
Price Target: $44 → $43
Current: $22.81
Upside: +88.51%
Aug 6, 2026
Reiterated: Buy
Price Target: $65
Current: $45.83
Upside: +41.83%
Jul 31, 2026
Reiterated: Buy
Price Target: $207 → $210
Current: $157.22
Upside: +33.57%
Jul 28, 2026
Rated: Buy
Price Target: $75
Current: $64.10
Upside: +17.00%
Jul 27, 2026
Reiterated: Buy
Price Target: $66
Current: $41.49
Upside: +59.07%
Jul 20, 2026
Reiterated: Buy
Price Target: $17
Current: $17.22
Upside: -1.28%
Jun 4, 2026
Reiterated: Hold
Price Target: $12
Current: $16.66
Upside: -27.97%
May 22, 2026
Reiterated: Buy
Price Target: $54 → $59
Current: $34.47
Upside: +71.16%
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $4.88
Upside: +63.93%
May 15, 2026
Reiterated: Buy
Price Target: $18
Current: $10.72
Upside: +67.91%
Apr 28, 2026
Upgraded: Hold
Price Target: $5 → $14
Current: $13.65
Upside: +2.56%
Apr 23, 2026
Reiterated: Buy
Price Target: $94 → $111
Current: $70.40
Upside: +57.67%
Apr 22, 2026
Reiterated: Buy
Price Target: $48 → $46
Current: $41.54
Upside: +10.74%
Mar 21, 2025
Downgraded: Hold
Price Target: $15 → $9
Current: $9.60
Upside: n/a
Nov 7, 2024
Reiterated: Hold
Price Target: $11 → $12
Current: $24.68
Upside: n/a
Oct 31, 2024
Reiterated: Sell
Price Target: $4.16
Current: $8.25
Upside: n/a
May 22, 2024
Reiterated: Buy
Price Target: $21 → $18
Current: $4.17
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $1 → $12
Current: $1.83
Upside: n/a
Aug 9, 2023
Downgraded: Sell
Price Target: $26 → $17
Current: $0.18
Upside: n/a
May 25, 2022
Reiterated: Buy
Price Target: $2
Current: $0.0077
Upside: n/a
Nov 10, 2021
Reiterated: Buy
Price Target: $20 → $3
Current: $26.26
Upside: n/a
May 6, 2021
Reiterated: Buy
Price Target: $6 → $175
Current: $0.0001
Upside: n/a
Jan 23, 2019
Upgraded: Hold
Price Target: n/a
Current: $27.72
Upside: n/a
Oct 12, 2017
Reiterated: Hold
Price Target: $3 → $2
Current: $1.24
Upside: n/a
Nov 11, 2013
Initiated Coverage: Buy
Price Target: $6
Current: $0.0003
Upside: n/a